Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$981M |
| 2 |
Apple
AAPL
|
+$704M |
| 3 |
Amazon
AMZN
|
+$670M |
| 4 |
Merck
MRK
|
+$431M |
| 5 |
NVIDIA
NVDA
|
+$414M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KSU
Kansas City Southern
KSU
|
+$441M |
| 2 |
JD.com
JD
|
+$196M |
| 3 |
Aon
AON
|
+$184M |
| 4 |
VER
VEREIT, Inc.
VER
|
+$165M |
| 5 |
Dell
DELL
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.2% |
| 2 | Healthcare | 13.25% |
| 3 | Financials | 13.01% |
| 4 | Consumer Discretionary | 11.99% |
| 5 | Communication Services | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OMIC
3251
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $2.6M | ﹤0.01% |
7,511
+2,968
| +65% | +$1.15M |
|
3252
Bassett Furniture
BSET
$173M
| $2.6M | ﹤0.01% |
155,103
-8,494
| -5% | -$147K |
|
3253
Cipher Digital
CIFR
$8.34B
| $2.59M | ﹤0.01% |
559,703
+517,245
| +1,218% | +$3.77M |
|
|
SEEL
3254
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $2.58M | ﹤0.01% |
413
-35
| -8% | -$269K |
|
3255
Tonix Pharmaceuticals
TNXP
$179M
| $2.58M | ﹤0.01% |
11
-1
| -8% | -$318K |
|
3256
Nautilus Biotechnolgy
NAUT
$125M
| $2.56M | ﹤0.01% |
495,198
+109,327
| +28% | +$585K |
|
|
RENT
3257
Rent the Runway
RENT
$123M
| $2.56M | ﹤0.01% |
+15,728
| New | +$4.19M |
|
3258
Werewolf Therapeutics
HOWL
$20.1M
| $2.55M | ﹤0.01% |
214,224
+77,752
| +57% | +$1.17M |
|
3259
TotalEnergies
TTE
$189B
| $2.54M | ﹤0.01% |
51,460
-2,234
| -4% | -$111K |
|
|
BGRY
3260
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $2.54M | ﹤0.01% |
462,403
+156,498
| +51% | +$899K |
|
3261
Information Services Group
III
$210M
| $2.54M | ﹤0.01% |
332,969
+50,827
| +18% | +$409K |
|
3262
Cadre Holdings
CDRE
$1.32B
| $2.54M | ﹤0.01% |
+99,768
| New | +$2.02M |
|
|
IMG
3263
DELISTED
CIMG Inc
IMG
| $2.53M | ﹤0.01% |
875
+840
| +2,400% | +$1.9M |
|
|
PZN
3264
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $2.53M | ﹤0.01% |
267,126
-6,511
| -2% | -$67.6K |
|
3265
Hurco Companies Inc
HURC
$139M
| $2.52M | ﹤0.01% |
85,021
+1,130
| +1% | +$36K |
|
3266
HDFC Bank
HDB
$123B
| $2.52M | ﹤0.01% |
77,436
-102
| -0.1% | -$3.57K |
|
|
MPX
3267
DELISTED
Marine Products Corp
MPX
| $2.52M | ﹤0.01% |
201,484
-18,186
| -8% | -$227K |
|
3268
Escalade
ESCA
$303M
| $2.51M | ﹤0.01% |
158,727
-2,046
| -1% | -$36.9K |
|
|
TECX
3269
Tectonic Therapeutic
TECX
$550M
| $2.5M | ﹤0.01% |
54,184
+6,110
| +13% | +$351K |
|
|
VINC
3270
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $2.5M | ﹤0.01% |
12,273
+1,383
| +13% | +$345K |
|
3271
VEON
VEON
$3.76B
| $2.47M | ﹤0.01% |
57,863
+1,056
| +2% | +$51.5K |
|
3272
Heritage Insurance Holdings
HRTG
$902M
| $2.47M | ﹤0.01% |
420,100
+33,419
| +9% | +$220K |
|
|
PVLA
3273
Palvella Therapeutics
PVLA
$2.18B
| $2.45M | ﹤0.01% |
8,109
-562
| -6% | -$180K |
|
3274
Lakeland Industries
LAKE
$119M
| $2.45M | ﹤0.01% |
112,861
+1,046
| +0.9% | +$21.4K |
|
3275
Dianthus Therapeutics
DNTH
$6.04B
| $2.44M | ﹤0.01% |
34,496
+1,479
| +4% | +$149K |
|
Similar funds
Geode Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Geode Capital Management held 5,071 positions worth $830B, up 12% from $743B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Geode Capital Management's Q4 2021 filing shows 216 new, 2,976 increased, 1,070 reduced and 95 closed positions. Its largest new stake was Rivian: 2,078,098 shares worth $215M. The largest sale was Kansas City Southern, an estimated $441M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q4 2021 buy was Rivian: 2,078,098 shares worth $215M.
- Geode Capital Management added most to Microsoft in Q4 2021, an estimated $981M increase.
- Geode Capital Management's biggest Q4 2021 reduction was JD.com, cutting an estimated $196M.
- Geode Capital Management fully exited Kansas City Southern in Q4 2021, selling an estimated $441M.
- Geode Capital Management's ten largest holdings make up 24% of its $830B portfolio in Q4 2021.
- Geode Capital Management opened 216 new positions and closed 95 in Q4 2021.
- Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $830B.
Based on Geode Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.